BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11488063)

  • 1. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
    Stevens EC; Rosenthal NS
    Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes.
    Dunphy CH
    Arch Pathol Lab Med; 2005 Feb; 129(2):219-22. PubMed ID: 15679425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
    Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
    Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histopathologic diagnosis of bone marrow in leukemia and related disorders].
    Kikuchi M; Ohshima K; Kobari S
    Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):47S-51S. PubMed ID: 2002263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome.
    Rønnov-Jessen D; Løvgreen Nielsen P; Horn T
    Bone Marrow Transplant; 1991 Nov; 8(5):413-5. PubMed ID: 1768977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic mastocytosis and secondary acute myeloid leukemia].
    Galán Alvarez P; Ibáñez García J; Funes Vera C; López García-Carreño MD; Alix Trueba A; Pérez Guillermo M; Alberola C
    An Med Interna; 1999 Sep; 16(9):466-8. PubMed ID: 10609361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
    Ohshima K; Kikuchi M; Takeshita M
    J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of the lymph node and spleen in systemic mast cell disease.
    Travis WD; Li CY
    Mod Pathol; 1988 Jan; 1(1):4-14. PubMed ID: 3237690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
    Akin C; Jaffe ES; Raffeld M; Kirshenbaum AS; Daley T; Noel P; Metcalfe DD
    Am J Clin Pathol; 2002 Aug; 118(2):242-7. PubMed ID: 12162685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
    Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
    Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells.
    Horny HP
    Am J Clin Pathol; 2009 Sep; 132(3):438-47. PubMed ID: 19687320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
    Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
    Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):47S-51S; discussion 50S, 60S-65S. PubMed ID: 16799609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic aspects of systemic mastocytosis.
    Parker RI
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):557-68. PubMed ID: 10909040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.